Trial Profile
A Phase 3, Randomized, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2014
Price :
$35
*
At a glance
- Drugs Chloroquine/azithromycin (Primary) ; Mefloquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Nov 2014 New trial record